Interlaboratory comparison of size measurements on nanoparticles using nanoparticle tracking analysis (NTA)

Journal of Nanoparticle Research

Volumn 15, Issue 12, 2013, Pages

  Hole, Patrick ^a   Sillence, Katherine ^a   Hannell, Claire ^a   Maguire, Ciaran Manus ^b   Roesslein, Matthias ^c   Suarez, Guillaume ^d   Capracotta, Sonja ^a   Magdolenova, Zuzana ^e   Horev Azaria, Limor ^f   Dybowska, Agnieszka ^g   Cooke, Laura ^h   Haase, Andrea ⁱ   Contal, Servane ^j   Manø, Stein ^e   Vennemann, Antje ^k   Sauvain, Jeans Jacques ^d   Staunton, Kieran Crosbie ^b   Anguissola, Sergio ^h   Luch, Andreas ⁱ   Dusinska, Maria ^e   Korenstein, Rafi ^f   Gutleb, Arno C ^j   Wiemann, Martin ^k   Prina Mello, Adriele ^b   Riediker, Michael ^d   Wick, Peter ^c   more..

^a MALVERN INSTRUMENTS LTD   (United Kingdom)

^b ST JAMES S HOSPITAL   (Ireland)

^c SWISS FEDERAL LABORATORIES FOR MATERIALS SCIENCE AND TECHNOLOGY   (Switzerland)

^d INSTITUTE FOR WORK AND HEALTH   (Switzerland)

^e NORWEGIAN INSTITUTE FOR AIR RESEARCH   (Norway)

^f TEL AVIV UNIVERSITY   (Israel)

^g DEPARTMENT OF LIFE SCIENCES   (United Kingdom)

^h UNIVERSITY COLLEGE DUBLIN   (Ireland)

ⁱ FEDERAL INSTITUTE FOR RISK ASSESSMENT   (Germany)

^j LUXEMBOURG INSTITUTE OF SCIENCE AND TECHNOLOGY   (Luxembourg)

^k UNIVERSITY OF MÜNSTER   (Germany)

more..

Author keywords

Health and safety implications; Interlaboratory comparison; Nanoparticle; Polydispersity; Reproducibility; Toxicology

Indexed keywords

EXPERIMENTAL FACILITIES; HEALTH AND SAFETY; INTERLABORATORY COMPARISON; NANOPARTICLE TRACKING ANALYSIS; PROTOCOL DEVELOPMENT; REPRODUCIBILITIES; RESEARCH INFRASTRUCTURE; TOXICOLOGY;

MEDICINE; NANOPARTICLES; POLYDISPERSITY;

PARTICLE SIZE;

NANOPARTICLE;

ARTICLE; COMPARATIVE STUDY; DISPERSION; MEASUREMENT; NANOANALYSIS; NANOMEDICINE; NANOPARTICLE TRACKING ANALYSIS; NATURAL SCIENCE; PARTICLE SIZE; PRIORITY JOURNAL; REPRODUCIBILITY;

EID: 84887508154     PISSN: 13880764     EISSN: 1572896X     Source Type: Journal    
DOI: 10.1007/s11051-013-2101-8     Document Type: Article

References (34)

1. ASTM (2012) ASTM E2834-12 Standard guide for measurement of particle size distribution of nanomaterials in suspension by nanoparticle tracking analysis (NTA). ASTM International, West Conshohocken. doi:10.1520/E2834-12
2. Casals E, Pfaller T, Duschl A, Oostingh G, Puntes V (2010) Time evolution of the nanoparticle protein corona. ACS Nano 4(7):3623-3632. doi:10.1021/nn901372t
3. Cedervall T, Lynch I, Lindman S, Berggård T, Thulin E, Nilsson H, Dawson K, Linse S (2007) Understanding the nanoparticle- protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles. Proc Natl Acad Sci USA 104(7):2050-2055. doi:10.1073/pnas.0608582104
4. De Jong W, Borm P (2008) Drug delivery and nanoparticles: applications and hazards. Int J Nanomed 3(2):133-149
5. Elsaesser A, Howard CV (2012) Toxicology of nanoparticles. Adv Drug Deliv Rev 64(2):129-137. doi:10.1016/j.addr.2011.09.001
6. Filipe V, Hawe A, Jiskoot W (2010) Critical evaluation of nanoparticle tracking analysis (NTA) by NanoSight for the measurement of nanoparticles and protein aggregates. Pharm Res 27(5):796-810. doi:10.1007/s11095-010-0073-2
7. Frisken B (2001) Revisiting the method of cumulants for the analysis of dynamic light-scattering data. Appl Opt 40(24):4087-4091
8. Fritz H, Maier M, Bayer E (1997) Cationic polystyrene nanoparticles: preparation and characterization of a model drug carrier system for antisense oligonucleotides. J Colloid Interface Sci 195(2):272-288. doi:10.1006/jcis.1997. 5172
9. Gaumet M, Vargas A, Gurny R, Delie F (2008) Nanoparticles for drug delivery: the need for precision in reporting particle size parameters. Eur J Pharm Biopharm 69(1):1-9. doi:10.1016/j.ejpb.2007.08.001
10. Greish K, Thiagarajan G, Herd H, Price R, Bauer H, Hubbard D, Burckle A, Sadekar S, Yu T, Anwar A, Ray A, Ghandehari H (2012) Size and surface charge significantly influence the toxicity of silica and dendritic nanoparticles. Nanotoxicology 6(7):713-723. doi:10.3109/17435390.2011.604442
11. Hanna S, Miller R, Muller E, Nisbet R, Lenihan H(2013) Impact of engineered zinc oxide nanoparticles on the individual performance of Mytilus galloprovincialis. PLoS One 8(4). doi:10.1371/journal.pone.0061800
12. Hassellöv M, Readman J, Ranville J, Tiede K (2008) Nanoparticle analysis and characterization methodologies in environmental risk assessment of engineered nanoparticles. Ecotoxicology 17(5):344-361. doi:10.1007/s10646-008- 0225-x
13. ISO (1994) ISO 5725-2: 1994: Accuracy (trueness and precision) of measurement methods and results. Part 2. Methods for the determination of repeatability and reproducibility. International Organization for Standardization
14. ISO (1998) ISO 5725-5: 1998, Accuracy (trueness and precision) of measurement methods and results. Part 5. Alternative methods for the determination of the precision of a standard measurement method. International Organization for Standardization, Geneva
15. ISO (2013) Resolution 254 of the ISO TC24 Plenary meeting, April 2013, Germany
16. JGCM 100 (2008) Evaluation of measurement data: guide to the expression of uncertainty in measurement. http://www.bipm.org/utils/common/documents/jcgm/ JCGM-100-2008-E.pdf
17. Jiang W, Kim B, Rutka J, Chan W (2008) Nanoparticle-mediated cellular response is size-dependent. Nat Nanotechnol 3(3):145-150. doi:10.1038/nnano. 2008.30
18. Kim D, Jeong YY, Jon S (2010) A drug-loaded aptamer-gold nanoparticle bioconjugate for combined CT imaging and therapy of prostate cancer. ACS Nano 4(7):3689-3696. doi:10.1021/nn901877h
19. Lin Y-S, Haynes C (2010) Impacts of mesoporous silica nanoparticle size, pore ordering, and pore integrity on hemolytic activity. J Am Chem Soc 132(13):4834-4842. doi:10.1021/ja910846q
20. Lison D, Huaux F (2011) In vitro studies: ups and downs of cellular uptake. Nat Nanotechnol 6(6):332-333
21. Mohamed BM, Verma NK, Davies AM, McGowan A, Crosbie-Staunton K, Prina-Mello A, Kelleher D, Botting CH, Causey CP, Thompson PR, Pruijn GJM, Kisin ER, Tkach AV, Shvedova AA, Volkov Y (2012) Citrullination of proteins: a common post-translational modification pathway induced by different nanoparticles in vitro and in vivo. Nanomedicine 7(8):1181-1195. doi:10.2217/nnm.11.177
22. Montes-Burgos I, Warczak D, Hole P, Smith J, Lynch I, Dawson K (2010) Characterisation of nanoparticle size and state prior to nanotoxicological studies. J Nanopart Res 12(1):47-53. doi:10.1007/s11051-009-9774-z
23. Nel AE, Madler L, Velegol D, Xia T, Hoek EMV, Somasundaran P, Klaessig F, Castranova V, Thompson M (2009) Understanding biophysicochemical interactions at the nano-bio interface. Nat Mater 8(7):543-557
24. OECD (2009) Guidance manual for the testing of manufactured nanomaterials: OECD sponsorship programme: first revision. OECD environment, health and safety publications series on the safety of manufactured nanomaterials, 25th edn. Paris
25. Prina-Mello A, Crosbie-Staunton K, Salas G, del Puerto Morales M, Volkov Y (2013) Multiparametric toxicity evaluation of SPIONs by high content screening technique: identification of biocompatible multifunctional nanoparticles for nanomedicine. Magnetics, IEEE Transactions on 49(1):377-382. doi:10.1109/tmag.2012.2225024
26. Roco MC (2011) The long view of nanotechnology development: the National Nanotechnology Initiative at 10 years. J Nanopart Res 13(2):427-445. doi:10.1007/s11051-010-0192-z
27. Roebben G, Ramirez-Garcia S, Hackley VA, Roesslein M, Klaessig F, Kestens V, Lynch I, Garner CM, Rawle A, Elder A, Colvin VL, Kreyling W, Krug HF, Lewicka ZA, McNeil S, Nel A, Patri A, Wick P, Wiesner M, Xia T, Oberdörster G, Dawson KA (2011) Interlaboratory comparison of size and surface charge measurements on nanoparticles prior to biological impact assessment. J Nanopart Res 13(7):2675-2687. doi:10.1007/s11051-011-0423-y
28. Salvati A, Pitek AS, Monopoli MP, Prapainop K, Bombelli FB, Hristov DR, Kelly PM, Aberg C, Mahon E, Dawson KA (2013) Transferrin-functionalized nanoparticles lose their targeting capabilities when a biomolecule corona adsorbs on the surface. Nat Nanotechnol 8(2):137-143. doi:10.1038/nnano.2012.237
29. Schrurs F, Lison D (2012) Focusing the research efforts. Nat Nanotechnol 7(9):546-548. doi:10.1038/nnano.2012.148
30. Tenzer S, Docter D, Rosfa S, Wlodarski A, Kuharev J, Rekik A, Knauer SK, Bantz C, Nawroth T, Bier C, Sirirattanapan J, Mann W, Treuel L, Zellner R, Maskos M, Schild H, Stauber RH (2011) Nanoparticle size is a critical physicochemical determinant of the human blood plasma corona: a comprehensive quantitative proteomic analysis. ACS Nano 5(9):7155-7167. doi:10.1021/nn201950e
31. Tiede K, Hassellöv M, Breitbarth E, Chaudhry Q, Boxall ABA (2009) Considerations for environmental fate and ecotoxicity testing to support environmental risk assessments for engineered nanoparticles. J Chromatogr A 1216(3):503-509. doi:10.1016/j.chroma.2008.09.008
32. Tong L, Wei Q, Wei A, Cheng J-X (2009) Gold nanorods as contrast agents for biological imaging: optical properties, surface conjugation and photothermal effects. Photochem Photobiol 85(1):21-32. doi:10.1111/j.1751-1097.2008.00507.x
33. Tsao TM, Chen YM, Wang MK (2011) Origin, separation and identification of environmental nanoparticles: a review. J Environ Monit 13(5):1156-1163. doi:10.1039/c1em10013k
34. Warheit DB (2008) How meaningful are the results of nanotoxicity studies in the absence of adequate material characterization? Toxicol Sci 101(2):183-185. doi:10.1093/toxsci/kfm279